ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia

Press/Media

Period	15 Apr 2025

Media coverage

Title	ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia
Media name/outlet	BioSpace
Country/Territory	United States
Date	15/04/25
URL	ct.moreover.com/?a=56502589733&p=1gw&v=1&x=g0Fy7K8tm5wf22gQV0XKaQ
Persons	Carlos Cordon-Cardo,